Health-related quality of life in the phase III ASCENT trial of sacituzumab govitecan versus standard chemotherapy in metastatic triple-negative breast cancer

  1. Loibl, S.
  2. Loirat, D.
  3. Tolaney, S.M.
  4. Punie, K.
  5. Oliveira, M.
  6. Rugo, H.S.
  7. Bardia, A.
  8. Hurvitz, S.A.
  9. Brufsky, A.M.
  10. Kalinsky, K.
  11. Cortés, J.
  12. O'Shaughnessy, J.A.
  13. Dieras, V.
  14. Carey, L.A.
  15. Gianni, L.
  16. Gharaibeh, M.
  17. Preger, L.
  18. Phan, S.
  19. Chang, L.
  20. Shi, L.
  21. Piccart, M.J.
Aldizkaria:
European Journal of Cancer

ISSN: 1879-0852,  0959-8049

Argitalpen urtea: 2023

Alea: 178

Orrialdeak: 23-33

Mota: Artikulua

DOI: 10.1016/J.EJCA.2022.10.003 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus